Stock Screener - US Stocks, Forex and ETFs Please enable JavaScript to view this page content properly Log In | Sign Up
Criteria:
1.Exchange: NYSE, NASDAQ
2.MACD(12,26,9) Crossed Above 0
  Back to MACD Stock Screener
 
           
   Symbol   Name   Industry   Sector   Exchange  Cap, mln  Last  Change  Change, %  Volume
 ACRS   Aclaris Therapts  Biotechnology Healthcare NASDAQ 42  1.63  -0.17 -9.4 6,750,944
 ADRU   Bldrs Europe Select ADR Index Fund Invesco  Investment Trusts Financial NASDAQ 10  20.57  0.02 0.097 100
 ADTN   Adtran Inc  Communication Equipment Technology NASDAQ 511  11.41  -0.17 -1.5 117,169
 AFL   Aflac Incorporated  Life & Health Insurance Financial NYSE 38,180  52.61  0.17 0.3 1,850,662
 AMJ   Alerian MLP Index ETN JP Morgan  Banks Financial NYSE 2,724  24.05  0.00 0.00 969,751
 AMU   Etracs Alerian MLP Index ETN  Exchange Traded Fund Financial NYSE 292  15.17  0.03 0.2 4,509
 ARAV   Aravive Inc  Biotechnology Healthcare NASDAQ 64  6.94  1.02 17.2 164,276
 ASMB   Assembly Biosciences  Biotechnology Healthcare NASDAQ 284  14.82  2.07 16.2 539,739
 ATRO   Astronics Cp  Aerospace/Defense Products & Services Industrial Goods NASDAQ 902  32.27  1.10 3.5 344,527
 AXR   Amrep Corp  Business Services Services NYSE 46  5.84  0.00 0.00 100
Please sign up for viewing the full list of stocks.


Education MACD - Technical Analysis from A to Z
The MACD (Moving Average Convergence/Divergence) is a trend following momentum indicator that shows the relationship between two moving averages of prices. The MACD is the difference between a 26-day and 12-day exponential moving average. A 9-day exponential moving average, called the "signal" line is plotted on top of the MACD to show buy/sell opportunities. The MACD proves most effective in wide-swinging trading markets. There are three popular ways to use the MACD: crossovers, overbought/oversold conditions, and divergences. Learn more




Disclaimer - Privacy Policy - Cookie Use Policy - FAQ - Contact Us
Copyright ©2008-2019 MarketInOut.com. All rights reserved.
Best viewed in